# Tonix Pharmaceuticals Holding Corp.: Form 8-K, filed Apr 23, 2026

- Company: [Tonix Pharmaceuticals Holding Corp.](/companies/tnxp.md) (CIK 1430306)
- Form: 8-K
- Filed: 2026-04-23
- Accepted by EDGAR: Apr 23, 2026, 07:11 ET
- Period: 2026-04-21
- Accession: 0001999371-26-008771
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1430306/000199937126008771/tnxp_8k-042226.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1430306/000199937126008771/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1430306/000199937126008771/tnxp_8k-042226.htm

Filed Apr 23, 2026.
Source: SEC EDGAR, the filing index for accession 0001999371-26-008771. Last ingested by Listed: Nov 14, 2026, 18:37 ET. No prices; not investment advice.
